D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder

Phase 2 Withdrawn University of Florida Obsessive Compulsive Foundation · collab

RandomizedSingle-groupOpen-label

Summary

We propose to undertake an initial study of DCS to determine whether it has any short-term clinical benefits when added to standard ERP therapy in adults with OCD.

Timeline

Start: 2005-07
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cycloserine	Small molecule	—	—

D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder

Summary

Timeline

Drugs

Indications